ebomi
Colour theme
Sign in
Insider · CIK 0001601086

Armistice Capital, LLC

CIK 0001601086 Name as filed on the most recent filing

Filed as Armistice Capital, LLC (196)

1,297 transaction lines · from 196 filings · filed 2017-05-09 to 2023-06-28 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2023-06-27 S, Open-market sale Avalo Therapeutics, Inc.AVTX 486,888, disposed Open Form 4 filing 0000899243-23-016659
2023-06-26 S, Open-market sale Avalo Therapeutics, Inc.AVTX 1,682,010, disposed Open Form 4 filing 0000899243-23-016659
2023-02-07 P, Open-market purchase Avalo Therapeutics, Inc.AVTX Not reported Open Form 4 filing 0000899243-23-004412
2022-03-14 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 64,940, acquired Open Form 4 filing 0000899243-22-010904
2022-03-11 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 68,780, acquired Open Form 4 filing 0000899243-22-010904
2022-03-10 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 18,226, acquired Open Form 4 filing 0000899243-22-010904
2022-03-07 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 213,330, acquired Open Form 4 filing 0000899243-22-009744
2022-03-04 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 95,108, acquired Open Form 4 filing 0000899243-22-009744
2022-03-03 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 35,695, acquired Open Form 4 filing 0000899243-22-009744
2022-02-25 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 31,716, acquired Open Form 4 filing 0000899243-22-008145
2022-02-24 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 80,090, acquired Open Form 4 filing 0000899243-22-008145
2022-02-22 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 64,076, acquired Open Form 4 filing 0000899243-22-007249
2022-02-18 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 45,238, acquired Open Form 4 filing 0000899243-22-007249
2022-02-17 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 122,250, acquired Open Form 4 filing 0000899243-22-007249
2022-01-20 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 10,208, acquired Open Form 4 filing 0000899243-22-002693
2022-01-19 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 82,053, acquired Open Form 4 filing 0000899243-22-002693
2022-01-18 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 182,225, acquired Open Form 4 filing 0000899243-22-002693
2022-01-14 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 78,974, acquired Open Form 4 filing 0000899243-22-002025
2022-01-13 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 314,013, acquired Open Form 4 filing 0000899243-22-002025
2022-01-12 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 59,781, acquired Open Form 4 filing 0000899243-22-002025
2022-01-11 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 15,342, acquired Open Form 4 filing 0000899243-22-001618
2022-01-10 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 484,615, acquired Open Form 4 filing 0000899243-22-001618
2022-01-07 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 142,975, acquired Open Form 4 filing 0000899243-22-001618
2021-09-17 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 11,999,999, acquired Open Form 4 filing 0000899243-21-036402
2021-09-16 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 341,955, acquired Open Form 4 filing 0000899243-21-036402
2021-09-15 P, Open-market purchase Avalo Therapeutics, Inc.AVTX 215,948, acquired Open Form 4 filing 0000899243-21-036402
2021-08-18 P, Open-market purchase Cerecor Inc.CERC 55,550, acquired Open Form 4 filing 0000899243-21-033505
2021-08-16 P, Open-market purchase Cerecor Inc.CERC 82,638, acquired Open Form 4 filing 0000899243-21-033505
2021-08-06 P, Open-market purchase Cerecor Inc.CERC 70,630, acquired Open Form 4 filing 0001567619-21-014631
2021-08-05 P, Open-market purchase Cerecor Inc.CERC 69,295, acquired Open Form 4 filing 0001567619-21-014631
2021-08-04 P, Open-market purchase Cerecor Inc.CERC 268,590, acquired Open Form 4 filing 0001567619-21-014631
2021-08-02 S, Open-market sale Eyegate Pharmaceuticals IncEYEG 463,046, disposed Open Form 4 filing 0001567619-21-014361
2021-07-30 S, Open-market sale Eyegate Pharmaceuticals IncEYEG 183,562, disposed Open Form 4 filing 0001567619-21-014361
2021-07-29 S, Open-market sale Eyegate Pharmaceuticals IncEYEG 1,200,000, disposed Open Form 4 filing 0000899243-21-030722
2021-07-28 S, Open-market sale Eyegate Pharmaceuticals IncEYEG 1,232,617, disposed Open Form 4 filing 0000899243-21-030722
2021-07-27 S, Open-market sale Eyegate Pharmaceuticals IncEYEG 5 lines 12,113,647, disposed Open Form 4 filing 0000899243-21-030722
2021-06-18 S, Open-market sale ReShape Lifesciences Inc.RSLS 3,756,995, disposed Open Form 4 filing 0000919574-21-004191
2021-06-18 S, Open-market sale ReShape Lifesciences Inc.RSLS Not reported Open Form 4 filing 0000919574-21-004191
2021-06-17 S, Open-market sale ReShape Lifesciences Inc.RSLS 6,354,033, disposed Open Form 4 filing 0000919574-21-004191
2021-06-17 S, Open-market sale ReShape Lifesciences Inc.RSLS 580,140, disposed Open Form 4 filing 0000919574-21-004191
2021-06-17 S, Open-market sale ReShape Lifesciences Inc.RSLS Not reported Open Form 4 filing 0000919574-21-004191
2021-06-17 S, Open-market sale ReShape Lifesciences Inc.RSLS Not reported Open Form 4 filing 0000919574-21-004191
2021-06-16 S, Open-market sale ReShape Lifesciences Inc.RSLS 2,530,053, disposed Open Form 4 filing 0000919574-21-004191
2021-06-16 S, Open-market sale ReShape Lifesciences Inc.RSLS 582,841, disposed Open Form 4 filing 0000919574-21-004191
2021-06-16 S, Open-market sale ReShape Lifesciences Inc.RSLS 426,341, disposed Open Form 4 filing 0000919574-21-004191
2021-06-16 S, Open-market sale ReShape Lifesciences Inc.RSLS Not reported Open Form 4 filing 0000919574-21-004191

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. ARMISTICE CAPITAL, LLC, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001601086

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.